Skip to content
10-K

Annual Report

FILANA THERAPEUTICS, INC. FLNA

0001437749-26-007962

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 9, 2026 48.31M sh
Shares Diluted FY 2025 · Dec 31, 2025 48.3M sh
Shares Diluted FY 2025 · Dec 31, 2024 46.6M sh
Shares Diluted FY 2025 · Dec 31, 2023 41.93M sh
Capex FY 2025 · Dec 31, 2025 $581K
Capex FY 2025 · Dec 31, 2024 $103K
Capex FY 2025 · Dec 31, 2023 $414K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$32.25M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$116.93M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$82.03M
Cash And Equivalents FY 2025 · Dec 31, 2025 $95.5M
Cash And Equivalents FY 2025 · Dec 31, 2024 $128.57M
Stockholders Equity FY 2025 · Dec 31, 2025 $74.4M
Stockholders Equity FY 2025 · Dec 31, 2024 $145.7M
Stockholders Equity FY 2025 · Dec 31, 2023 $137.47M
Stockholders Equity FY 2025 · Dec 31, 2022 $227.54M
Current Liabilities FY 2025 · Dec 31, 2025 $43.83M
Current Liabilities FY 2025 · Dec 31, 2024 $11.75M
Total Liabilities FY 2025 · Dec 31, 2025 $43.95M
Total Liabilities FY 2025 · Dec 31, 2024 $11.83M
Current Assets FY 2025 · Dec 31, 2025 $97.71M
Current Assets FY 2025 · Dec 31, 2024 $136.53M
Total Assets FY 2025 · Dec 31, 2025 $118.36M
Total Assets FY 2025 · Dec 31, 2024 $157.53M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.88
Eps Diluted FY 2025 · Dec 31, 2024 −$1.46
Eps Diluted FY 2025 · Dec 31, 2023 −$2.32
Eps Basic FY 2025 · Dec 31, 2025 −$1.88
Eps Basic FY 2025 · Dec 31, 2024 −$0.53
Eps Basic FY 2025 · Dec 31, 2023 −$2.32
Sga Expense FY 2025 · Dec 31, 2025 $68.8M
Sga Expense FY 2025 · Dec 31, 2024 $71.81M
Sga Expense FY 2025 · Dec 31, 2023 $16.53M
Rd Expense FY 2025 · Dec 31, 2025 $26.59M
Rd Expense FY 2025 · Dec 31, 2024 $69.64M
Rd Expense FY 2025 · Dec 31, 2023 $89.42M
Net Income FY 2025 · Dec 31, 2025 −$90.97M
Net Income FY 2025 · Dec 31, 2024 −$24.34M
Net Income FY 2025 · Dec 31, 2023 −$97.22M
Operating Income FY 2025 · Dec 31, 2025 −$95.39M
Operating Income FY 2025 · Dec 31, 2024 −$141.45M
Operating Income FY 2025 · Dec 31, 2023 −$105.96M